Rabo Frontier Ventures and existing backer AgFunder contributed to a series A-plus round taking the farming networking platform developer’s overall funding to $32m.
Month: March 2021
Mooe Robot picks up new funding
Existing investor Deppon Express was among the participants in a round for the robotic forklift developer sized at roughly $15m.
Ibex annexes $38m in series B round
Dell Technologies Capital returned for a round that took the cancer diagnostics technology developer’s overall funding to $52m.
Songclip splices in $11m
Kraft Group and IHeartMedia Ventures were among the investors that helped the licensed music provider double its total funding to $22m.
Grifols grabs GigaGen in $80m acquisition
Grifols has agreed to buy the remaining 56% of antibody drug developer GigaGen having invested $35m four years ago.
Wrapbook folds in $27m
WndrCo contributed to a series A round for Wrapbook, the creator of a mobile platform that can handle payment for film crews.
Visus Therapeutics invites investors to $36m round
Johnson & Johnson Innovation – JJDC helped the eye drop developer close a series A round that will fund development of lead asset Brimochol.
Temasek’s $500m strategic partnership with LeapFrog Investments
It is the first significant initiative from Singapore state-backed investor Temasek’s new CEO-designate but the $500m strategic partnership with UK-based impact investor LeapFrog Investments is a powerful statement.
Roblox locks up direct listing
The Tencent and Warner Music-backed game development platform looks set to maintain its $29.5bn valuation in its direct listing today.
Valo Health sails to $300m series B close
Koch Disruptive Technologies has provided $110m for the drug discovery technology startup’s series B round following a $190m first close in January.
Evolv graduates to $1.25bn reverse merger
Motorola Solutions is among the participants supplying $300m in PIPE financing as the contactless security system developer agrees to list through a reverse takeover.
DTCP accepts Axonius stake in $270m deal
Deutsche Telekom-backed DTCP was among a group of investors that acquired a $270m stake in the cybersecurity management platform developer in a secondary transaction.
Paige upgrades series C round to $125m
The computational pathology technology provider has added $25m to a round co-led by Johnson & Johnson Innovation – JJDC.
Edgewise nears $100m IPO
Novo will exit the musculoskeletal disease drug developer, should the latter complete an initial public offering on the Nasdaq Global Market.